Chemistry-aware AI accelerates drug discovery

Friends, sharing an update from the AI frontier: Connor Coley’s team at MIT is developing models that embed chemical principles for designing and synthesizing small molecules.

ShEPhERD evaluates candidate drug molecules by 3D shape and is already in use by pharma companies.

FlowER predicts reaction products while enforcing physical constraints—mass conservation and realistic intermediates.

The lab combines machine learning, cheminformatics, and automation to plan syntheses and cut experimental burden.

Why it matters: mechanistic grounding makes predictions more reliable and speeds drug development.

What steps are needed to deploy such models in industry?

#AI #Chemistry #Biopharma #MachineLearning